Compare BNTC & SFST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BNTC | SFST |
|---|---|---|
| Founded | 1995 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 420.3M | 421.9M |
| IPO Year | 2020 | 2012 |
| Metric | BNTC | SFST |
|---|---|---|
| Price | $11.75 | $51.70 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 1 |
| Target Price | $27.67 | ★ $64.00 |
| AVG Volume (30 Days) | ★ 183.7K | 69.9K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 80.94 | ★ 94.76 |
| EPS | N/A | ★ 3.72 |
| Revenue | N/A | ★ $6,282,000.00 |
| Revenue This Year | N/A | $10.47 |
| Revenue Next Year | N/A | $12.19 |
| P/E Ratio | ★ N/A | $14.21 |
| Revenue Growth | N/A | ★ 12.99 |
| 52 Week Low | $9.85 | $29.80 |
| 52 Week High | $17.15 | $62.00 |
| Indicator | BNTC | SFST |
|---|---|---|
| Relative Strength Index (RSI) | 51.44 | 36.04 |
| Support Level | $11.30 | $50.27 |
| Resistance Level | $12.75 | $52.60 |
| Average True Range (ATR) | 0.77 | 2.09 |
| MACD | 0.18 | -0.66 |
| Stochastic Oscillator | 45.16 | 15.28 |
Benitec Biopharma Inc is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The Company is developing a silence and replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life threatening genetic disorder.
Southern First Bancshares Inc is a bank holding company. The company engaged in the business of accepting demand deposits and savings deposits insured by the Federal Deposit Insurance Corporation (the FDIC), and providing commercial, consumer and mortgage loans to the general public of which a majority of the revenue is derived from the Commercial and Retail Banking segment which includes the provision of traditional deposit and lending products and services to its commercial and retail banking clients.